We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


BioWisdom Launches Sofia KnowledgeScan™

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

BioWisdom has announced the launch of Sofia KnowledgeScan™. Sofia KnowledgeScan™ is designed to exploit BioWisdom’s Sofia Intelligence Platform to provide information to support critical healthcare-related decision making. 

Launched in response to customer feedback, Sofia KnowledgeScan™ enables a systematic analysis of available data to tease out intelligence that is relevant to specific commercially sensitive medical issues such as unexpected side-effects or toxicities. 

Rapid deployment of BioWisdom’s Healthcare Intelligence methodology is provided without the immediate need for technology installations and training. 

Clients will also have access to BioWisdom’s industry-trained specialised healthcare analysts, who can lead the research and present an unbiased expert opinion on the analysed data. 

"BioWisdom specialises in constructing Intelligence Networks, which provide a robust and intuitive method of navigating and analysing complex, multi-dimensional biomedical intelligence," said Gordon Smith Baxter, CEO of BioWisdom.

"Our competitive advantage lies in our combination of pharmaceutical R&D experience, our proprietary intelligence software and our robust methodology."

"We have developed our approach over several years working with international pharma companies, such as AstraZeneca, Pfizer, Johnson & Johnson, GSKEli Lilly and Roche."